SEC Form 4 · accession 0001209191-16-142167
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Hochman
Director
Period of report
Sep 16, 2016
Accepted (ET)
Sep 20, 2016 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option(right to buy)F1 | $7.14 | Sep 16, 2016 | A | 50,000 | A | — | Sep 16, 2026 | Common Stock | 50,000 | 50,000 | I |
Explanation of responses
- F1The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and 50% of the option award will vest on the three-month anniversary of the date of grant with the remainder of the option award vesting on the six-month anniversary of the date of grant.